Mode
Text Size
Log in / Sign up

Endoplasmic reticulum stress and unfolded protein response drive thyrocyte apoptosis and immune cell dysfunctionEndoplasmic Reticulum Stress Linked to Hashimoto's Thyroiditis Development

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that ER stress may drive thyrocyte apoptosis and immune dysfunction, though evidence is currently limited to cell lines.

This narrative review explores the role of endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) in the pathogenesis of Hashimoto's thyroiditis (HT). The authors synthesize evidence regarding how the continuous production of thyroglobulin creates a saturated folding load on the ER, making thyroid follicular cells vulnerable. They argue that multiple HT-associated factors can activate the UPR, leading to thyrocyte apoptosis, suppression of functional genes, and loss of epithelial phenotype.

Furthermore, the review suggests that specific UPR branches may regulate the differentiation and function of infiltrating immune cells. However, the authors note that direct evidence in human patients is limited; only thyrocyte ERS activation and the macrophage IRE1α pathway have received preliminary direct evidence in HT or experimental autoimmune thyroiditis (EAT).

A primary limitation noted by the authors is that most components of the proposed feedback loop are supported by data from thyroid cell lines or non-thyroid experimental systems rather than human clinical data. The review proposes a testable model where thyrocyte ERS and immune effector amplification mutually reinforce each other, but clinicians should interpret these findings as a theoretical framework with limited direct evidence in humans.

How this fits prior evidence

This narrative review addresses the pathogenesis of Hashimoto's thyroiditis by proposing a mechanism involving endoplasmic reticulum stress. It expands upon existing knowledge regarding Hashimoto's thyroiditis, such as the observation that the COVID-19 pandemic was associated with an increase in Hashimoto's cases and the consideration of dietary modifications for patients with comorbid Celiac disease.

This review looks at how endoplasmic reticulum stress (ERS) affects thyroid cells in people with Hashimoto's thyroiditis. The study focuses on how the constant production of certain proteins can overwhelm the cell, leading to a state of stress known as the unfolded protein response (UPR).

Researchers found that this cellular stress may lead to cell death and the loss of normal cell functions. Additionally, different parts of this stress response might influence how immune cells behave in the body. However, it is important to note that most of this evidence comes from cell lines or experimental systems rather than direct studies on human patients.

While the study suggests a cycle where thyroid cell damage and immune system activity reinforce each other, only a few specific pathways have been directly observed in human-related models. Because much of the data is preliminary and based on laboratory models, these findings are currently used to help scientists understand the underlying biology of the condition rather than providing immediate changes for clinical treatment.

What this means for you:
Research suggests cellular stress may drive Hashimoto's thyroiditis, but more human studies are needed.

Common questions

What is endoplasmic reticulum stress in the context of thyroid health?

Endoplasmic reticulum stress (ERS) occurs when a cell is overwhelmed by the amount of protein it must fold. In Hashimoto's thyroiditis, the constant production of thyroglobulin can put the cell under a heavy load, potentially leading to a stress response that affects how the thyroid cells function.

How does this stress affect immune cells?

The study suggests that different branches of the unfolded protein response (UPR) may regulate how immune cells differentiate and function. This means that cellular stress in the thyroid might influence the way the immune system reacts in people with Hashimoto's thyroiditis.

Is this finding a proven cause for Hashimoto's thyroiditis?

The evidence is currently limited. While the study proposes a model where cell stress and immune responses reinforce each other, most of the data comes from cell lines or non-thyroid systems. Only two specific pathways have received preliminary direct evidence in human-related models.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
Hashimoto’s thyroiditis (HT) is the most prevalent autoimmune thyroid disease, characterized by lymphocytic infiltration and destruction of thyroid follicular architecture. Prior research has predominantly focused on aberrant adaptive immune activation, whereas the contribution of the thyroid follicular cell itself to this process remains incompletely elucidated. This narrative review synthesizes evidence implicating endoplasmic reticulum stress (ERS) in HT pathogenesis, stratifying the evidence by its proximity to HT pathology into three tiers: direct evidence, thyroid-cell evidence, and extrapolated evidence. Thyroid follicular cells continuously produce large quantities of structurally complex thyroglobulin, placing the ER under near-saturated folding load even under physiological conditions, thereby conferring an organ-specific vulnerability. Multiple HT-associated factors can activate the unfolded protein response (UPR), mediating thyrocyte apoptosis, suppression of functional genes, and loss of epithelial phenotype in thyroid cell models; individual UPR branches may also regulate the differentiation and function of infiltrating immune cells. Integrating the above evidence, this review proposes a testable positive-feedback perspective in which thyrocyte ERS injury and immune effector amplification may mutually reinforce one another. This perspective comprises six steps, and for each step, the strength of supporting evidence is assessed. Among these, only thyrocyte ERS activation and the macrophage IRE1α pathway have received preliminary direct evidence in HT or experimental autoimmune thyroiditis (EAT); support for the remaining steps derives primarily from thyroid cell lines or non-thyroid experimental systems.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.